Cargando…
Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
Ionizing radiation (IR) is used to treat 50% of cancers. While the cytotoxic effects related to DNA damage with IR have been known since the early 20th century, the role of the immune system in the treatment response is still yet to be fully determined. IR can induce immunogenic cell death (ICD), wh...
Autores principales: | Hannon, Gary, Lesch, Maggie L., Gerber, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138513/ https://www.ncbi.nlm.nih.gov/pubmed/37108522 http://dx.doi.org/10.3390/ijms24087359 |
Ejemplares similares
-
Harnessing immunological targets for COVID-19 immunotherapy
por: Mehata, Abhishesh Kumar, et al.
Publicado: (2021) -
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021) -
Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy
por: Hino, Christopher, et al.
Publicado: (2023) -
Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015) -
Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
por: Rajani, Karishma R., et al.
Publicado: (2019)